Especifique uma ação ou criptomoeda na barra de pesquisa para obter um resumo
Kingworld Medicines Group Ltd
1110Kingworld Medicines Group Limited, an investment holding company, primarily engages in the distribution and sale of branded imported pharmaceutical and healthcare products. The company offers products for relieving cough, alleviating phlegm, soothing asthma, enhancing respiratory system, aiding digestion, promoting intestinal health, activating blood circulation, relieving pain, combating flu, and other categories under the Nin Jiom Chuan Bei Pei Pa Koa, Taiko Seirogan, Kingworld Imada Red Flower Oil, Culturelle probiotics product series, Lifeline Care product serices, and Mentholatum product series brands. It also manufactures and sells electrotherapeutic and physiotherapeutic devices, and general medical examination devices; and supplies pharmaceutical, healthcare, general foodstuffs, and medical products. In addition, the company is involved in the distribution and sale of artwork; organization of art exhibition; distribution and sale of Chinese medicine; and engages in technology transfer and property investment activities. It serves in the People's Republic of China, Japan, the United States, Canada, Hong Kong, Taiwan, Thailand, the United Kingdom, Germany, Italy, Spain, Mexico, and internationally. The company was founded in 1996 and is headquartered in Shenzhen, the People's Republic of China. Address: Majialong Chuangxin Building, Shenzhen, China, 518016
Analytics
Preço Alvo de Wall Street
14.08 HKDRácio P/E
7.75Rendimento de dividendos
7.31 %Ano atual
Ano passado
Trimestre Atual
Ultimo quarto
Ano atual
Ano passado
Trimestre Atual
Ultimo quarto
Figuras chave 1110
Análise de Dividendos 1110
Crescimento de dividendos em 5 anos
-28 %Crescimento contínuo
2 anosTaxa de pagamento em média de 5 anos
55 %Histórico de Dividendos 1110
Avaliação de ações 1110
Relatório 1110
Acompanhe as principais métricas de cada ação em um só lugar, sem complicações
Inscreva-se no premiumResultados | 2019 | Dinâmica |